The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel

The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin

Anatole Besarab, W. Kline Bolton, Joan C. Egrie et al. · New England Journal of Medicine · 1998 · 1.9K citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

Christopher Heeschen, Alexandra Aicher, Ralf Lehmann et al. · Blood · 2003 · 837 citations

Life Sciences, Cell Biology, Physiology +9

Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction

Michael Davis, Patrick C.H. Hsieh, Tomosaburo Takahashi et al. · Proceedings of the National Academy of Sciences · 2006 · 613 citations · Full text

Engineering, Bioengineering, Biotechnology +17

Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells

Michael Davis, J. P. Michael Motion, Daria A. Narmoneva et al. · Circulation · 2005 · 578 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

A novel protective effect of erythropoietin in the infarcted heart

Cyrus J. Parsa, Akio Matsumoto, Ji Hee Kim et al. · Journal of Clinical Investigation · 2003 · 549 citations · Full text

Medicine, Cardiology, Pharmacology +15